Benzinga | Dec 17, 2021 12:37PM EST

Pfizer Whale Trades For December 17

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer.

Looking at options history for Pfizer (NYSE:PFE) we detected 31 strange trades.

If we consider the specifics of each trade, it is accurate to state that 35% of the investors opened trades with bullish expectations and 64% with bearish.

From the overall spotted trades, 4 are puts, for a total amount of $244,943 and 27, calls, for a total amount of $1,345,730.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $70.0 for Pfizer over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Pfizer's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $40.0 to $70.0 in the last 30 days.

Pfizer Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:



Symbol PUT/ Trade Sentiment Exp. Strike Total Trade Open Volume CALL Type Date Price Price InterestPFE CALL SWEEP NEUTRAL 12/23/ $63.00 $171.8K 7.4K 3.3K 21PFE PUT TRADE BULLISH 12/17/ $65.00 $112.0K 730 481 21PFE CALL SWEEP BULLISH 09/16/ $60.00 $80.5K 16.4K 188 22PFE CALL SWEEP BULLISH 12/17/ $55.00 $72.9K 57.2K 2.8K 21PFE CALL TRADE NEUTRAL 02/18/ $55.00 $71.2K 20.8K 541 22

Where Is Pfizer Standing Right Now?

* With a volume of 40,109,447.00, the price of PFE is down -3.18% at $59.3.

* RSI indicators hint that the underlying stock may be approaching overbought.

* Next earnings are expected to be released in 46 days.

What The Experts Say On Pfizer:

* Wells Fargo downgraded its action to Overweight with a price target of $60

* Morgan Stanley has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $60.

* Mizuho has decided to maintain their Neutral rating on Pfizer, which currently sits at a price target of $56.

* BMO Capital downgraded its action to Outperform with a price target of $60

* Barclays has decided to maintain their Equal-Weight rating on Pfizer, which currently sits at a price target of $54.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.